Post My Press Release

Free Press Release Distribution

Category: Healthcare (Page 1 of 225)

Thoracic Drainage Devices Market: Increase in Incidences of Pneumothorax and Pleural Effusion to Drive the Market

The demand within the global market for thoracic drainage devices is rising on account of the heavy incidence of pleural effusion in recent times. The large vendors in the global thoracic drainage devices have been looking for new inlets to enter into regional and local markets. This quest of the large marker vendors in the global thoracic drainage devices market owes to their intent to expand their consumer base. Despite the strong position of the leading companies in the market for thoracic drainage devices, the smaller vendors have not held back from trying their fortunes in the market.

Report Overview: https://www.transparencymarketresearch.com/thoracic-drainage-devices-market.html

The past decade has seen the commencement of several new companies in the global market thoracic drainage devices. This has brought a slight increase in the bar of competition for the global thoracic drainage devices market. The leading companies in the global market for thoracic drainage devices have not left any stone unturned in averting the entry of new players into the market. This is being done to ensure that the strong foothold of these key companies remains unaffected in the years to come.

The global market for thoracic drainage devices would expand at a healthy CAGR of 6% over the period between 2017 and 2025. Furthermore, the market for thoracic drainage devices was valued at US$ 555.8 Mn in 2016, and is expected to reach a value of US$ 916.2 Mn by the end of 2025. Based on the product type, trocar drains are in great popularity across the globe. On the basis of geography, the market for thoracic drainage devices in Europe has been expanding at a stellar rate.

Report Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40529

A large number of people have been affected by cardiac diseases over the past decade which has invited pragmatic reform steps across the medical sector. There is a need to ensure the availability of state of the art devices, equipments, and services across hospitals and healthcare centers. This factor has given an impetus to the growth of the global market for thoracic drainage devices in recent times. Furthermore, the growing incidence of pneumothorax has also aided the growth of the global thoracic drainage devices market in recent times.

The health of the lungs depends on their ability to drain fluid, blood, or air from the thoracic space, and this function can be blocked due to several diseases and complications. Since thoracic drainage devices help in restoring the functionality of the thoracic area, the relevance of these devices for the medical sector is immense. The preference of the masses for minimally invasive procedures has also given an impetus to the growth of the global market for thoracic drainage devices. Furthermore, the investment made by government entities towards making available key devices within healthcare has also propelled market demand.

Request Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40529

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Point of Care Diagnostics Market Size Growth Share Analysis Report 2019

Market Overview:

Point of Care Diagnostics Market size was valued for USD 22,975 million in 2018 and is expected to reach USD 43,336 million by 2023, growing at a CAGR of 9.4% from 2018 to 2023. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others.

Market Drivers and Restraints:

The primary factor fostering its growth is ongoing R&D activities due to increasing cancer prevalence. The advent of cancer detection by monitoring and analyzing circulating tumor cells has improved cancer research and diagnosis. Moreover, the launch of several home-testing cancer kits is expected to drive the segment growth in various healthcare settings.

To know more, click on the link below:

https://www.marketdataforecast.com/market-reports/point-of-care-diagnostics-market

Report segmented as:

By Product:

  • Infectious diseases
  • Cardiac markers
  • Oncology markers
  • OTC diagnostic tests
  • Drugs of abuse
  • Blood gas testing
  • Fertility testing
  • Urinalysis
  • Coagulation
  • Hematology
  • Glucose monitoring
  • Ambulatory chemistry
  • Decentralized clinical chemistry
  • Others

By End-users:

  • Clinics
  • Hospitals
  • Home Healthcare
  • Ambulatory care setting
  • Laboratories
  • Others

By Mode of Delivery:

  • OTC
  • Prescription

Geographical analysis:

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to lead the overall market in the next five years due to the presence of premium healthcare infrastructure, established reimbursement framework and high healthcare affordability in this region. Emerging markets such as China, India, and Brazil offer high growth potential for companies involved in the development and distribution of point of care diagnostic devices. Rising initiatives by market players, growing patient population base, an increase in the range of partnerships and joint ventures among point of care providers are the key factors driving the growth of point of care diagnostics market in emerging countries.

Important market players:

The key players operating in the market include F. Hoffmann-La Roche Ltd.; Danaher Corporation; Abbott Laboratories; bioMérieux SA; Instrumentation Laboratory SpA; Nova Biomedical; Trividia Health, Inc.; QIAGEN; Becton Dickinson & Company; Sekisui Diagnostics LLC; Quidel Corporation; and Siemens Healthcare GmbH.c

View a sample and decide @ https://www.marketdataforecast.com/market-reports/point-of-care-diagnostics-market/request-sample

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com

Tel: +1-888-702-9626

Website: https://www.marketdataforecast.com/

Europe Real Time Polymerase Chain Reaction (qPCR) Market Size Is Anticipated To Reach USD 95.8 Million By 2022 : Grand View Research Inc.

San Francisco, 16 May 2019: The Report Europe Real Time Polymerase Chain Reaction (qPCR) Market Analysis By Instrument (7500, Quantstudio Dx, ViiA 7 Dx, StepOne/StepOne Plus, LightCycler 2.0, Cobas 4800, LightCycler 480, CFX96, SmartCycler, Rotor-Gene Q, MasterCycler), And Segment Forecasts to 2022

Europe Real Time Polymerase Chain Reaction (qPCR) Market is expected to reach over USD 395.8 million by 2022, according to a new report by Grand View Research Inc. Technological advancements on the grounds of accuracy, portability, and cost-effectiveness are expected to serve this market as high-impact rendering drivers over the forecast period. For instance, Applied Biosystems has QuantStudio Dx series for rapid and affordable diagnosis of molecular abnormalities at early stage of diseases development. 

Increasing amount of R&D expenditure by the major players and development of novel assay kits are expected to provide potential growth platform for adoption of qPCR instruments for diagnostic use. 

Growing prevalence of cancer and other chronic diseases is anticipated to be the key driver for the industry growth. Moreover, growing geriatric population base in EU-28 countries is expected to increase age-related conditions such as diabetes and cardiovascular disorders. 

Furthermore, major pharmaceutical companies are entering into collaborations with diagnostic instrument development companies through mergers and acquisitions or co-product development activities. For instance, in 2011, Life Technologies signed an agreement with GSK Biologicals to develop a companion diagnostic test. Life Technology will develop a qPCR based diagnostic assay for GSK’s MEGA-A3 cancer immunotherapy.

Emerging opportunities for both companies for development of products pertaining to early detection of diseases such as cancer and infectious diseases are estimated to enhance such collaborative activities over the forecast period. 

Access Research Report of Europe Real Time Polymerase Chain Reaction (qPCR) Market @ www.grandviewresearch.com/industry-analysis/europe-real-time-polymerase-chain-reaction-market

Further key findings from the study suggest:

  • Thermo Fisher/ABI dominated the market with a revenue share of over 38% in 2014 owing to high installed base of instruments such as StepOne, 7500, ViiA 7, and QuantStudio from ABI
  • Bio-Rad qPCR instruments market is the second largest in terms of revenue share over USD 7.0 million in 2014. Presence of licensing agreement with companies such as Mobidiag in Europe for the distribution Bio-Rad qPCR instruments, availability of user-friendly software and good technical support are some factors attributing for its high market coverage.
  • Thermo Fischer Scientific, Roche, Bio-Rad, and Qiagen accounted for over 84% of market share in 2014. Product development and distribution agreements are the key strategies adopted by the company for its growth. Whereas, the four countries namely UK, Germany, Spain and France covered around 56% of the total European market for qPCR used as IVD platform in 2014.
  • Germany dominated the European market with revenue of around USD 9.5 million in 2014. It is estimated to be one of the major countries for use of In-Vitro Diagnostics (IVD) platform in Europe.
  • The UK is expected to witness significant growth with a CAGR of around 13% over the forecast period owing to rising prevalence of target diseases and introduction of new automated technologies.
  • Countries such as France and Spain are experiencing economic growth over the past few years; these countries are expected to offer immense potential for Europe real time PCR industry mainly due to growing economy and high unmet needs
  • Market participants are constantly engaged in the introduction of technological advancements. The real time PCR instruments market involves extensive technological advancements to match user requirements. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Europe Real Time Polymerase Chain Reaction (qPCR) market on the basis of instrument and region:

Europe real time PCR Market Instrument Outlook (Revenue, USD Million, Volume, Units, 2015 – 2022)

  • Applied Biosystems/Life Technologies
    • 7500
    • QuantStudio Dx Reagents
    • ViiA 7 Dx
    • StepOne/StepOne Plus
  • Roche
    • LightCycler 2.0
    • Cobas 4800
    • LightCycler 480
  • Bio-Rad
    • CFX96
  • Cepheid
    • SmartCycler
  • Qiagen
    • Rotor-Gene Q
  • Eppendorf
    • MasterCycler

Europe real time PCR Market Country Outlook(Revenue, USD Million, Volume, Units, 2015 – 2022)

  • UK
  • Germany
  • France
  • Spain

Access Press Release of Europe Real Time Polymerase Chain Reaction (qPCR) Market @ www.grandviewresearch.com/press-release/europe-qpcr-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Metal Nanoparticles Market Global Industry Overview and Competitive Landscape till 2022

The [149 Pages Report] “Metal Nanoparticles Market by metal (Platinum, Gold, Silver, Iron, Titanium, Copper, Nickel), End-use industry (Pharmaceutical & healthcare, Electrical & electronics, Catalyst, Personal care & cosmetics), and Region – Global Forecast to 2022″ published by MarketsandMarkets™, the Metal Nanoparticles Market size is estimated to grow from USD 12.35 Billion in 2017 to USD 25.26 Billion by 2022, at a CAGR of 15.4%. The market is projected to witness steady growth in the next few years, because of the increasing application areas of metal nanoparticles, resulting from rapid industrialization and urbanization. Large-scale investments in industrial sectors, rise in demand for innovative materials from the healthcare industry, and supportive government initiatives & funding are some of the key factors driving the growth of the Metal Nanoparticles Market.

Request for free PDF sample report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138262033

The metal nanoparticles market is led by major players such as American Elements (US), Nanoshel (US), Nanostructured & Amorphous Materials (US), EPRUI Nanoparticles & Microspheres (China), and US Research Nanomaterials (US). Extensive product portfolio, coupled with network of facilities across the globe, contributes toward the leading position of these market players. The market players focus on the advancement of sustainable technologies, commercializing emerging green technology, and promoting greater eco-efficiency which further boosts their market position in the global metal nanoparticles market.

 American Elements (US) is a leading metal nanoparticles manufacturer. Strong global presence, wide product portfolio comprising over 15,000 products, and focus toward the advancement of sustainable technologies have helped the company to establish a leading position in metal nanoparticles market. Its fundamental expertise in the cost-effective manufacturing of engineered and advanced materials enables the company to meet the demand of thousands of global customers. Through its network of production facilities globally, it also produces customer proprietary formulations. Its customer base in multiple countries further contributes to its leading position.

 Nanoshel (US) is another key player in the metal nanoparticles market. It is the manufacturer and supplier of innovative materials & nanoparticles and offers breakthrough solutions through its expertise in nanomaterials.

Its strong global presence with offices in both developed and developing countries, wide variety of metal nanoparticles, and skilled R&D team strengthen its position in the global market. The company is focused on developing innovative technologies and exploring markets to expand its market presence.

The global metal nanoparticles market is dominated by players such as American Elements (US), Nanoshel (US), Nanostructured & Amorphous Materials (US), EPRUI Nanoparticles & Microspheres (China), US Research Nanomaterials (US), Meliorum Technologies (US), nanoComposix (US), BBI Group (UK), Nanocs (US), Strem Chemicals (US), and Tanaka Holdings (Japan).

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Metal Nanoparticles Market.

Read our blog for more details: https://chemabd007.blogspot.com/2019/05/metal-nanoparticles-market-is-expected.html

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Market Data Forecast

BCG Vaccine Market Size Growth Demand Analysis Report 2019

BCG Vaccine Market Overview:

BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that. A single dose is given to an infant soon after birth in countries with a high occurrence of TB. In countries which TB is not a common occurrence, only high-risk infants are treated with it. Adults are only treated with this vaccine if their exposure to drug-resistant TB is a regular occurrence.

BCG Vaccine Market Size Growth Rate:

BCG Vaccine Market size was worth USD 20,366 in 2016 and is expected to reach USD 28,051 by 2023, growing at a CAGR of 4.6% from 2018 to 2023. Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine presently available for prevention of tuberculosis (TB). In countries with a high prevalence of tuberculosis, one dose is recommended for healthy babies close to the time of birth.

View for Full Report Analysis @ https://www.marketdataforecast.com/market-reports/bcg-vaccine-market

Market drivers and restraints:

The growing number of cases of TB all over the world particularly in the developing countries of APAC, quick advancements in technology in the field of medical research on vaccines, and savory government policies and initiatives with better funding are driving the growth of this market. Adverse side-effects of this vaccine and supply bottlenecks all around the world are projected to hinder market growth in the forecast period.

Report segmented as:

By Demographics:

  • Pediatrics (0-18 years)
  • Adults (19-35 years)

Geographical analysis:

Classification by geography encompasses Latin America, North America, Europe, the Middle East, and Africa as well as the Asia Pacific. North America accounted for the most significant market share while Asia Pacific is projected to grow with the highest CAGR due to TB elimination campaigns going on in the developing countries.

Get our Sample Report @ https://www.marketdataforecast.com/market-reports/bcg-vaccine-market/request-sample

Prominent Players of the Market:

  1. Sanofi Pasteur
  2. Merck & Co., Inc.
  3. Japan BCG Laboratory
  4. China National Biotec Group
  5. Serum Institute of India Pvt. Ltd.
  6. GreenSignal Bio Pharma Limited (GSBPL)
  7. InterVax Ltd.
  8. Statens Serum Institute.

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com

Tel: +1-888-702-9626

Website: https://www.marketdataforecast.com/

Chronic Obstructive Pulmonary Disease Treatment Market to Surge at a Robust Pace in Terms of Revenue Over 2018 -2026

Chronic Obstructive Pulmonary Disease Treatment Market – Snapshot

The global chronic obstructive pulmonary disease (COPD) treatment market is driven by increase in the number of COPD cases, rise in FDA approvals, and launch of several products in the U.S. Moreover, increase in the geriatric population and rise in expenditure on pharmaceuticals in emerging countries are the other factors contributing to the growth of the market. However, patent expiry of branded products and availability of generic equivalents and alternative treatment options are anticipated to restrain the global market.

View Report: https://www.transparencymarketresearch.com/chronic-obstructive-pulmonary-disease-treatment-market.html

Based on drug class, the global chronic obstructive pulmonary disease treatment market has been segmented into combination, bronchodilators, corticosteroids, phosphodiesterase type 4 inhibitors, mucokinetics, and others. The combination segment has been classified into long acting muscarinic antagonist & inhaled corticosteroids (LAMA-ICS), long acting beta agonist & inhaled corticosteroids (LABA-ICS), triple therapy, and others. The bronchodilators segment has been divided into long acting beta agonist (LABA), short acting beta agonist (SABA), and long acting muscarinic antagonist (LAMA). The combination segment is projected to account for major share of the market by 2026 due to increase in number of physicians prescribing combination therapy and surge in the number of drugs available for COPD treatment. The bronchodilators segment is anticipated to grow at a steady pace owing to increase in the adoption of long acting muscarinic antagonist (LAMA) drugs. In terms of distribution channel, the market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is expected to expand at the fastest CAGR due to surge in the number of patients preferring retail pharmacies. The online pharmacies segment is likely to be driven by rise in awareness about these pharmacies among the general population.

Based on region, the global chronic obstructive pulmonary disease (COPD) treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the global market in 2017. Presence of established pharmaceutical companies, increase in adoption of new drugs launched in the market, and focus on launch of new products through R&D are anticipated to drive the market in the region during the forecast period.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60156

The chronic obstructive pulmonary disease (COPD) treatment market in Europe is driven by increase in R&D expenditure and launch of new products. In November 2018, GlaxoSmithKline plc and Innoviva, Inc. received authorization from the European Commission for expanded use for once-daily Trelegy Ellipta, first single inhaler triple therapy indicated for COPD patients who were not adequately treated with dual bronchodilation.

Rise in prevalence of COPD, high environmental pollution, increase in the geriatric population, and growth of the pharmaceutical industry are anticipated to fuel the growth of the chronic obstructive pulmonary disease (COPD) treatment market in Asia Pacific. An article published in the International Journal of Pulmonary and Respiratory Sciences stated that COPD is the third leading cause of death in India.

The chronic obstructive pulmonary disease (COPD) treatment market in Latin America and Middle East & Africa is expected to be driven by increase in awareness about the diagnosis and treatment of COPD, rise in the number of government initiatives to spread awareness and importance about its treatment, and surge in the number of specialty care centers for respiratory care in various countries in the Middle East. Additionally, GCC Countries such as the UAE and Saudi Arabia present significant opportunities in the market due to strengthening health care system and availability of quality care in hospitals.

Request a Sample of the Report @  https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60156

Major players operating in the global chronic obstructive pulmonary disease (COPD) treatment market include AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc, Novartis AG, CHIESI Farmaceutici S.p.A., Sunovion Pharmaceuticals, Inc. (Sumitomo Dainippon Pharma Co., Ltd), Teva Pharmaceutical Industries Ltd., Mylan N.V., and Orion Corporation.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Human Identity Testing Market to Showcase Vigorous Demand during the Period until 2026

Molecular biology has evolved as a technologically advanced tool for the identification and testing of various human traits. Human DNA serves as a unique identification parameter, used by numerous scientists and biologists for testing human identity. Human identity testing is performed to confirm the genealogical relationship or identify human remains. In identity testing, DNA profiling is performed for the comparison and identification of suspects, linking scene and incidents in a crime scene investigation, and paternal testing, among others. Patterns generated by the unknown DNA samples are compared to the known DNA genome sequence to resolve paternity disputes and other applications that require large amounts of intact DNA. Increase in research grants by private institutes to promote R&D of novel human identity testing products, and rise in awareness regarding human identity testing kits & services among forensics and law department are few key factors boosting the human identity testing market during the forecast period. However, probability of manual errors during the procedure of human identity testing and requirement for well-qualified and trained professionals to conduct the testing are expected to restrain the human identity testing market during the forecast period.

Obtain Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43466

The global human identity testing market is categorized based on product type, application, end-user, and region. In terms of product, the global human identity testing market is segmented into software and instruments. The instruments segment, also known as kits, accounted for a considerable share of the market in 2017, which is attributed to high throughput analysis, cost-effectiveness, and rise in demand for efficient court-compliant DNA sampling products. Increase in demand for complex relationship testing and ancestry testing is projected to boost the segment during the forecast period. Based on technology, the global human identity testing market is segmented into electrophoresis, Polymerase Chain Reaction (PCR), microarray, and others. PCR is a popular technique for human identity testing owing to its high accuracy rate. PCR is expected to continue dominating the market during the forecast period due to the introduction of technologically innovative PCR-based human identity testing kits and high preference in forensic laboratories. However, microarray technology is projected to expand significantly during the forecast period. In terms of end-user, the global human identity testing market is categorized into research laboratories, academic institutes, forensic laboratories, government institutes, and others. In terms of revenue, the forensic laboratories segment is estimated to account for large share of the market by 2026. Dominance of this segment is attributed to high number of DNA profiling and human identity testing performed for criminal cases. Rise in demand for mass disaster victim identification and missing person identification is estimated to increase government institutes during the forecast period. This, in turn, is projected to boost the market.

Geographically, the global human identity testing market is categorized into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for largest market share in 2016, due to availability of platforms for biotechnological research activities. Increase in distribution of commercial human identity testing kits and presence of key players in the U.S. and Canada are likely to drive the market in North America during the forecast period. Increase in demand for parentage testing and immigrant testing in developing countries of Asia Pacific is projected to fuel the market in the region by 2026.

Request for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43466

Key players operating in the human identification testing market include GE Healthcare, Thermo Fisher Scientific Inc., Genex Diagnostics, Inc., Illumina, Inc., Tecan Trading AG, Agilent Technologies Inc., Eurofins Scientific, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Alere, InnoGenomics Technologies, LLC, and Trinity DNA Solutions.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Global Medical Textile Market, Competitors, Industry Trends and Forecast to 2018-2025

Bharat Book Bureau Provides the Trending Market Research Report on “Global Medical Textile Market Size study, by Product Type Level (Non-Woven Products, Knitted Products, Woven Products), Industry Level (Implantable Goods, Non-Implantable Goods, Healthcare & Hygiene Products), Channel Level (Direct Sales, Distributors) and Regional Forecasts 2018-2025” under Healthcare category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Global Medical Textile Market is valued approximately USD 16.11 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2018-2025. Medical textiles are combination of medical science and textile technology including fabrics and yarns. Additionally, medical textiles are produced and designed for various medical applications including surgical dressing, anti-microbial fabrics, vascular prosthesis (Grafts), Nerve reconnection and regeneration, bandages, surgical gowns and others. These structures are accomplished and designed for various medical applications ranging from a single thread structure to the complex structures and from the simple cleaning wipe to bone replacement. Moreover, medical textiles and fabrics are also used in operating rooms.

Request a free sample copy of Medical Textile Market Report @ https://www.bharatbook.com/marketreports/Sample/Reports/1533365

Medical textiles are broadly classified into Non-woven, Knitted and Woven products that plays a key role in maintaining hygiene in healthcare sector. Increasing demand for medical textile products and fabrics with rising importance of hygiene and need for safety in medical industry have boosted the demand for medical textile market across the globe. The market growth is primarily attributed to rising awareness towards better healthcare practices and technological advancements for achieving the safety and quality standards. Growing demand of nanofibers in medical industry is the key trend gaining momentum in forecasted years for global medical textile market. These nanofibers are manufactured using biodegradable or biocompatible materials having high growth potential in healthcare and biomedical sector. Increasing healthcare expenditure and strict regulations to ensure safety and quality of medical textile products is promoting the market growth. According to Institute for Health Metrics and Evaluation, global healthcare expenditure would increase to USD 18.28 trillion by 2040. High-income countries are likely to spend approx. USD 9,019 per person on health that is comparably much higher than the spending by middle-income countries that is expected to be USD 1,935. Countries with lower income would be spending USD 164 per person on an average till 2040.

Furthermore, due importance is given on improving the medical safety and hygiene in medical industry. To ensure the same, stringent regulations with various test have been imposed on the manufacturing industries supplying medical fibers that in turn regulates the demand for medical textiles across the globe.

The regional analysis of global medical textile market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to escalating number of surgical procedures and surging disposable income of the individuals. Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2018-2025 due to escalating number of road accidents and surging number of cosmetic procedures.

Market player included in this report are:

Bally Ribbon

Freudenberg

Vestagen Technical

Bluestar Silicones

Atex Technologies

Biomedical Structures

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type Level:

Non-Woven Products

Knitted Products

Woven Products

By Industry Level:

Implantable Goods

Non-Implantable Goods

Healthcare & Hygiene Products

By Channel Level:

Direct Sales

Distributors

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Browse our full report with Table of Contents : https://www.bharatbook.com/marketreports/global-medical-textile-market-size-study-by-product-type-level-non-woven-products-knitted-products-woven-products-/1533365

About Bharat Book Bureau:

Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Industry Trends & Analysis, Forecasts & Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email: poonam@bharatbook.com

Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn



Page 1 of 225

Powered by WordPress & Theme by Anders Norén